Recent developments
AI summary of recent coverageRecent coverage has focused on Yaniv Cohen's appointment as interim CEO of IR-Med, Inc., alongside the company's advancement of its DiaSafe device into first-in-human clinical trials for diabetic foot ulcer assessment. The company has also received recognition in the health technology sector for its innovation.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Yaniv Cohen, it will appear here — and tie into the news timeline.
Yaniv Cohen: FAQ
- What company does Yaniv Cohen lead?
- Yaniv Cohen is CEO of IR-Med, Inc..